Microarray patches (MAPS) can revolutionize vaccine delivery in developing countries thanks to it being cost-effective, safe, easy to distribute and requiring less training to administer.

This innovative vaccine delivery method has now reached an important milestone with positive results from measles-rubella MAP studies in Africa.

To learn more about the benefits and latest research on MAPs read the article below written by Rajinder Suri and Aila Marini in VaccinesWork by Gavi, the Vaccine Alliance.

Click here to read the full article.